Skip to content
NB EN
Nettsak

AI diagnoses rare diseases better than doctors - Nature study shows the way

# AI can find rare diseases faster than doctors, Nature study shows For people with rare diseases, the road to the right diagnosis can be long, demanding and full of false leads. N...

Håkon Berntsen 3 min read
AI diagnoses rare diseases better than doctors - Nature study shows the way
Illustrasjon: Nettsak
# AI can find rare diseases faster than doctors, Nature study shows For people with rare diseases, the road to the right diagnosis can be long, demanding and full of false leads. Now a new study published in *Nature* shows that artificial intelligence can help make diagnoses faster and more accurately than traditional methods, while the system explains how it arrived at the answer. ## A possible breakthrough for millions of patients More than 300 million people worldwide live with a rare disease. For many, it takes several years to get a correct diagnosis, often after a long series of examinations, referrals and misdiagnoses. The new AI system has been developed to meet precisely this challenge. The goal is not just to suggest the right diagnosis, but to give doctors a better basis for decisions when the clinical picture is complicated and unusual. ## How the system works The AI solution combines three key data sources: 1. Clinical data: Symptoms, blood tests and diagnostic imaging 2. Genetic information: DNA sequencing and mutation analysis 3. Medical literature: Millions of research articles and case studies What makes the system particularly interesting is that it does not just deliver an answer. It also shows the reasoning behind the diagnosis. A doctor can thus see which symptoms, genetic markers and research findings the AI bases its assessment on. This makes the technology more verifiable and easier to use in clinical practice. ## Why this could change diagnostics Diagnosing rare diseases is among the most demanding tasks in medicine. Many conditions are so unusual that even experienced specialists only encounter them once or twice in the course of a career. The challenges are considerable: - 7-8 years is the average waiting time for a diagnosis - Several misdiagnoses are common along the way - More than 7,000 rare diseases make the field highly complex - No doctor can know everything, even with a high level of specialist expertise Here AI may have a clear advantage. The system can: - Analyse all 7,000+ diseases simultaneously - Compare findings against millions of case studies - Detect patterns that humans easily overlook In practice, this could mean that a patient with unclear symptoms and rare genetic changes gets help finding the right diagnosis far earlier than today. ## A concrete example of the benefit Imagine a child with a combination of neurological symptoms, unusual blood tests and a rare genetic mutation. In today's system, the family may be sent between different specialists for years before anyone sees the whole picture. An AI system that connects symptoms, genetic data and published research can instead identify a possible rare diagnosis early and show which findings point in that direction. This can save the patient, the family and the health service time, strain and unnecessary tests. ## Highly relevant for Norway too Norway has a high incidence of certain rare diseases, partly because of genetic founder effects in certain populations. Such tools could therefore be of great importance here at home too. A system like this could in time: - Reduce the time to diagnosis from years to weeks - Lower healthcare costs by cutting unnecessary tests - Provide better quality of life for patients and families For Norwegian hospitals and health trusts, this could become an important tool in the work on personalised medicine. ## What happens next? The study is published in *Nature*, which is regarded as one of the world's most respected scientific journals. The next step is clinical testing at hospitals to see how the technology works in real patient pathways. If the results hold up in practice, this could be an important step towards a future where rare diseases are detected earlier, treated faster and understood better. Norwegian health trusts should therefore follow developments closely. This could become a central part of the medicine of the future. Sources: Nature, ScienceDaily

Related stories